文献速递MDS 与骨髓增殖性肿瘤

骨髓增生异常综合征患者健康相关生活质量低下的决定因素:EUMDS登记研究

Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study.
PubMed 文献 · Blood Adv · 2023-01-01

该研究基于EUMDS登记研究,纳入2205例新诊断骨髓增生异常综合征(MDS)患者,评估诊断后第一年的纵向数据,以EQ-5D-3L指数中位数0.78和VAS评分中位数0.70为低生活质量阈值,采用广义估计方程多变量分析识别低生活质量的独立决定因素。

要点

  • 低EQ-5D指数独立决定因素包括年龄增长、女性、高铁蛋白、合并症负担和KPS降低。
  • 低VAS评分额外决定因素包括输血依赖、血红蛋白<10 g/dL和高体重指数。
  • 性别、KPS、合并症负担、血红蛋白和输血负担是所有EQ-5D维度的决定因素。

核心结论

  • 低健康相关生活质量由多因素决定,应在MDS患者的管理和共享决策中加以考虑。

研究设计与样本

  • EUMDS登记研究,评估2205例MDS患者诊断后第一年的纵向数据,试验注册号NCT00600860。

主要发现

  • 低EQ-5D指数的独立决定因素:年龄60-75岁OR 1.33(95%CI 1.01-1.75),年龄>75岁OR 1.84(95%CI 1.39-2.45),女性OR 1.70(95%CI 1.43-2.03),血清铁蛋白≥1000 vs ≤300 μg/L OR 1.41(95%CI 1.06-1.87),合并症负担每单位OR 1.11(95%CI 1.02-1.20),KPS每10单位OR 0.62(95%CI 0.58-0.67)。
  • 低VAS评分的额外决定因素:输血依赖OR 1.53(95%CI 1.03-2.29),血红蛋白<10 g/dL OR 1.34(95%CI 1.12-1.61),体重指数≥30 vs 23-29.9 kg/m2 OR 1.26(95%CI 1.02-1.57)。
  • 性别、KPS、合并症负担、血红蛋白计数和输血负担是所有EQ-5D维度的决定因素。

临床怎么用

  • 原文结论认为低健康相关生活质量由多因素决定,应在MDS患者的管理和共享决策中加以考虑。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with myelodysplastic syndromes (MDS) frequently experience a significant symptom burden, which reduces health-related quality of life (HRQoL). We aimed to identify determinants of low HRQoL in patients recently diagnosed with MDS, for guiding early intervention strategies. We evaluated longitudinal data in 2205 patients with MDS during their first year after diagnosis. Median values of EQ-5D 3-level (EQ-5D-3L) index (0.78) and visual analog scale (VAS) score (0.70) were used as thresholds for low HRQoL. In addition, the 5 dimensions of EQ-5D-3L were analyzed for impairments (any level vs "no problem" category). After multiple imputation of missing values, we used generalized estimating equations (GEE) to estimate odds ratios (OR) for univariable determinant screening (P < .15), and to subsequently derive multivariable models for low HRQoL with 95% confidence intervals (CI). Multivariable GEE analysis showed the following independent determinants (OR, 95% CI) for low EQ-5D index: increased age (60-75 years: 1.33, 1.01-1.75; >75: 1.84, 1.39-2.45), female sex (1.70, 1.43-2.03), high serum ferritin level (≥1000 vs ≤300 μg/L: 1.41, 1.06-1.87), comorbidity burden (per unit: 1.11, 1.02-1.20), and reduced Karnofsky performance status (KPS, per 10 units: 0.62, 0.58-0.67). For low VAS score, additional determinants were transfusion dependence (1.53, 1.03-2.29), low hemoglobin <10 g/dL (1.34, 1.12-1.61), and high body mass index (≥30 vs 23-29.9 kg/m2: 1.26, 1.02-1.57). Sex, KPS, comorbidity burden, hemoglobin count, and transfusion burden were determinants for all EQ-5D dimensions. Low HRQoL is determined by multiple factors, which should be considered in the management and shared decision making of patients with MDS. This trial was registered at www.clinicaltrials.gov as #NCT00600860.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Stojkov I, Conrads-Frank A, Rochau U, et al. Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study. Blood Adv. 2023. PMID: 36607832. doi:10.1182/bloodadvances.2022008360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。